Screener
Ligand Pharmaceuticals LGND Proceeds from Pelthos investors bridge loans
Proceeds from Pelthos investors bridge loans at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept lgnd:ProceedsFromInvestorsFinancingActivities.
The source filing: Ligand Pharmaceuticals’s 10-K, filed February 27, 2026. Open the filing →
- Filed
- Feb 27, 2026, 4:02 PM EST
- Fiscal year
- FY2025
- Accession
- 0000886163-26-000006
FAQ
- What is Ligand Pharmaceuticals's proceeds from pelthos investors bridge loans?
- Ligand Pharmaceuticals (LGND) reported proceeds from pelthos investors bridge loans of $1.73M in Q4 2025.
- What does proceeds from pelthos investors bridge loans mean?
- Cash inflows derived from bridge loans or other short-term financing arrangements provided by external investors. This metric indicates the company's reliance on interim funding sources to support operations or specific projects before long-term financing is secured. It highlights the company's access to capital markets and short-term liquidity management.
Ask your AI about Ligand Pharmaceuticals's proceeds from pelthos investors bridge loans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude